摘要
伯克霍尔德菌属是一个高度多样化的种群,在各种环境和生境中广泛存在。这一种群中,以对广泛的环境条件(包括消毒剂和有机试剂)的适应力而著称,代表着一些最难治疗的感染性亚群。这个亚群包括类鼻疽伯克霍尔德菌,类鼻疽的病原体;鼻疽伯克霍尔德氏菌,类鼻疽的病原体和洋葱伯克霍尔德复合体 (Bcc) 等导致囊纤维化和免疫低下患者的机会性感染。后者病原体本身就是一个由18个不同但密切相关的物种组成的群体。这个群体的适应性允许分子毒力因子大量的选择表达来促进其在多种生境中生存。本文将描述这些与人类感染相关的选择;比较三种病原体且强调其作为候选疫苗的潜在作用。更好的整合伯克霍尔德菌群发病机制和分子毒力因子的相关知识可有利于更有效疫苗的开发。
关键词: 洋葱伯克霍尔德复合体, 鼻疽伯克霍尔德氏菌,类鼻疽伯克霍尔德菌,囊纤维化,鼻疽,类鼻疽,疫苗,毒力。
Current Medicinal Chemistry
Title:Exploiting Molecular Virulence Determinants in Burkholderia to Develop Vaccine Antigens
Volume: 22 Issue: 14
Author(s): William Thomas Casey and Siobhan McClean
Affiliation:
关键词: 洋葱伯克霍尔德复合体, 鼻疽伯克霍尔德氏菌,类鼻疽伯克霍尔德菌,囊纤维化,鼻疽,类鼻疽,疫苗,毒力。
摘要: The Burkholderia genus is a highly diverse group of species that are distributed throughout a wide range of environments and habitats. Among this group, which is remarkable for its adaptability to a wider range of environmental conditions including disinfectants and organic solvents, are a subgroup that represents some of the most difficult to treat infections. This subgroup includes Burkholderia pseudomallei, the causative agent of melioidosis; B. mallei, the causative agent of glanders and B. cepacia complex (Bcc) which causes opportunistic infections in people with cystic fibrosis and immunocompromised patients. The latter pathogen is itself a group of 18 distinct, but, closely related species. The adaptability of this group allows the expression of a rich selection of molecular virulence determinants to facilitate its survival in the diverse habitats that it colonises. This review will describe a selection of these associated with human infection; comparing them across the three pathogens and highlighting their potential roles as vaccine candidates. Better integration of the knowledge on the pathogenesis and molecular determinants of virulence for these Burkholderia spp may allow the development of more efficacious vaccines.
Export Options
About this article
Cite this article as:
William Thomas Casey and Siobhan McClean , Exploiting Molecular Virulence Determinants in Burkholderia to Develop Vaccine Antigens, Current Medicinal Chemistry 2015; 22 (14) . https://dx.doi.org/10.2174/0929867322666150408111304
DOI https://dx.doi.org/10.2174/0929867322666150408111304 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Alzheimer’s Disease and Molecular Chaperones: Current Knowledge and the Future of Chaperonotherapy
Current Pharmaceutical Design Targeting Matrix Metalloproteinases in Inflammatory Conditions
Current Drug Targets Zoledronic Acid Use and Risk of Cognitive Decline among Elderly Women and Men with Osteoporosis
Endocrine, Metabolic & Immune Disorders - Drug Targets Aspirin: from a Historical Perspective
Recent Patents on Cardiovascular Drug Discovery What’s Age Got to do with it? A Review of Contemporary Revascularization in the Elderly
Current Cardiology Reviews New Uses of Melatonin as a Drug; A Review
Current Medicinal Chemistry Mechanisms of Enhanced Vasoconstriction in the Mouse Model of Atherosclerosis: the Beneficial Effects of Sildenafil
Current Pharmaceutical Biotechnology Novel Coronavirus Disease (COVID-19): A Narrative Review Based on Current Status
Anti-Infective Agents The Prostaglandin Agonist Beraprost Aggravates Doxorubicin-mediated Apoptosis by Increasing iNOS Expression in Cardiomyocytes
Current Vascular Pharmacology Levosimendan: A New Inodilatory Drug for the Treatment of Decompensated Heart Failure
Current Pharmaceutical Design Preface
Combinatorial Chemistry & High Throughput Screening Preoperative Levosimendan. A New Way for Organoprotection
Current Pharmaceutical Design Nanowired Drug Delivery of Antioxidant Compound H-290/51 Enhances Neuroprotection in Hyperthermia-Induced Neurotoxicity
CNS & Neurological Disorders - Drug Targets Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Current Drug Targets Stress Echocardiography
Current Pharmaceutical Design Effects of Maternal Obesity on Maternal and Fetal Health
Current Women`s Health Reviews Human Ascariasis: An Updated Review
Recent Patents on Inflammation & Allergy Drug Discovery Assessment of Acute Coronary Syndromes: Focus on Novel Biomarkers
Current Medicinal Chemistry Lone Atrial Fibrillation- A Diagnosis of Exclusion
Current Pharmaceutical Design Chest Trauma: The Role of Injury Severity Scoring
Current Respiratory Medicine Reviews